sponsored a 24-week, randomized, placebo-controlled obesity trial (N=536) testing oral AOD-9604 at doses of 1 mg, 5 mg, 10 mg, and 20 mg daily
This type of study is important for several reasons: it tells us how long the peptide remains active in the body, what breakdown products are formed (which could themselves have biological activity or be used as markers in drug testing), and helps explain why AOD9604 needs to be administered in certain ways to remain effective
OpenSource Diets formula D12451) or, if they were previously on an LD, they were maintained continued on LD (termed lean control mice)
PROTECT FROM LIGHT STORE AT CONTROLLED ROOM TEMPERATURE 20-25C (68-77 F) [SEE USP CONTROLLED ROOM TEMPERATURE] For Single use Only
How often will I need the injection
Women specific considerations Women generally require lower doses relative to body weight compared to men